Nice one...
Good to see an increase in number of Biomarkers to be observed, namely (but not necessarily limited to):
- COMP
- C terminal telopeptide (CTX) -II
- NGF, interleukin (IL) -1ß,
- TNFa,
- IL-6
- A disintegrin and metalloproteinase with thrombospondin motif 5 (ADAMTS-5),
- ARGS (aggrecan cleavage fragments)
- Tissue inhibitor matrix metalloproteinase 1 (TIMP-1)
- CTX-I
- Type II collagen (C2C)
Quite a comprehensive study also looking at Pain, Function and Stiffness along with Serum samples.
Will be illustrative to get a comparison between Synovium and Serum activity and the effects of iPPS on each.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $174.8M | |||
| Open | High | Low | Value | Volume |
| 42.5¢ | 46.0¢ | 42.0¢ | $347.2K | 796.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16968 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.5¢ | 2449 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |